Annual Drug Patent Expirations for THALOMID Thalomid is a drug marketed by Bristol-myers and is included in one NDA. It is available from one supplier. There is one patent protecting…
Posts published in “Patent Expiration”
Annual Drug Patent Expirations for OTEZLA Otezla is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
Annual Drug Patent Expirations for XOPENEX+HFA Xopenex Hfa is a drug marketed by Lupin and is included in one NDA. It is available from five suppliers. There are two patents…
STRIVERDI RESPIMAT (olodaterol hydrochloride) Boehringer ingelheim Patent: 7,056,916 Expiration: Dec 7, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen…
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen…
Annual Drug Patent Expirations for ZAVZPRET Zavzpret is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are three patents protecting…
OXAYDO (oxycodone hydrochloride) Zyla Patent: 7,981,439 Expiration: Nov 26, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or…
Annual Drug Patent Expirations for OXAYDO Oxaydo is a drug marketed by Zyla and is included in one NDA. It is available from one supplier. There are six patents protecting…
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Zr Pharma and is included in one NDA. It is available from two suppliers. There are twelve patents…
